Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents

被引:34
作者
Saczewski, Franciszek [1 ]
Stencel, Agnieszka [1 ]
Bienczak, Andrzej M. [1 ]
Langowska, Karolina A. [1 ]
Michaelis, Martin [2 ]
Werel, Wladyslaw [3 ]
Halasa, Rafal [3 ]
Reszka, Przemyslaw [4 ]
Bednarski, Patrick J. [4 ]
机构
[1] Med Univ Gdansk, Dept Chem Technol Drugs, PL-80416 Gdansk, Poland
[2] Univ Frankfurt, Inst Med Virol, Univ Clin, D-60596 Frankfurt, Germany
[3] Med Univ Gdansk, Dept Pharmaceut Microbiol, PL-80416 Gdansk, Poland
[4] Ernst Moritz Arndt Univ Greifswald, Dept Pharmaceut & Med Chem, Inst Pharm, D-17487 Greifswald, Germany
关键词
Acrylonitriles; (Benzimidazol-1)acetamides; Cytotoxicity; Antibacterial; Structure-activity relationships; Anticancer;
D O I
10.1016/j.ejmech.2007.11.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Eighteen new 2,6-disubstituted acrylonitriles and two new (benzimidazol-1-yl)-acetamide derivatives were prepared and screened for antibacterial and cytotoxic activities on 12 human cancer cell lines. Based on the lead structure 2-(benzimidazol-2-yl)-3-(5-nitrothiophen-2-yl) acrylonitrile it was found that placement of methyl groups at the 5,6 positions of the benzimidazole ring lead to a 3-fold increase in overall cytotoxic activity. Replacing the nitrothiophene for pyridine reduced cytotoxic activity as did replacing the nitro group for a methoxy group. Cytotoxic activity was only slightly reduced when the benzimidazole ring was replaced by a imidazo[4,5-b]pyridine or a benzthiazole ring but replacement by benzoxazole led to a substantial decrease in activity. Moving the acrylonitrile group from position 2 to position 1 of the benzimidazole ring also resulted in moderately active compounds. (Benzimidazol-1-yl)acetamides showed only modest activity. The structure-activity relationships found in the cytotoxicity studies are mirrored in the results of the antibacterial experiments. (C) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1847 / 1857
页数:11
相关论文
共 24 条
[1]   Determination of minimum inhibitory concentrations [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :5-16
[2]   Reaction of 2-hetarylacetonitriles with ethyl 2-alkylsulfanyl-4-chloro-5-pyrimidinecarboxylates. Synthesis of new condensed pyrimidines [J].
Blyumin, EV ;
Volovenko, YM ;
Neunhoeffer, H ;
Shishkina, SV ;
Zubatyuk, RA ;
Shishkin, OV .
TETRAHEDRON, 2002, 58 (28) :5733-5740
[3]   Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines:: comparisons with the National Cancer Institute data [J].
Bracht, K ;
Boubakari ;
Grünert, R ;
Bednarski, PJ .
ANTI-CANCER DRUGS, 2006, 17 (01) :41-51
[4]   Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives [J].
Brzozowski, Z ;
Saczewski, F .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (09) :709-720
[5]  
BUKOWSKI L, 1986, POL J PHARMACOL PHAR, V38, P91
[6]   Synthesis and antiproliferative activity of 3-aryl-2-(1H-benzotriazol-1-yl)acrylonitriles.: Part III [J].
Carta, A ;
Sanna, P ;
Palomba, M ;
Vargiu, L ;
La Colla, M ;
Loddo, R .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (11) :891-900
[7]  
Carta Antonio, 2004, Farmaco (Lausanne), V59, P637, DOI 10.1016/j.farmac.2004.03.004
[8]   The preparation and reactions of 2-benzimidazolecarboxylic acid and 2-benzimidazoleacetic acid [J].
Copeland, RAB ;
Day, AR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1943, 65 :1072-1075
[9]   Effects of positional and geometrical isomerism on the biological activity of some novel oxazolidinones [J].
Das, J ;
Rao, CVL ;
Sastry, TVRS ;
Roshaiah, M ;
Sankar, PG ;
Khadeer, A ;
Kumar, MS ;
Mallik, A ;
Selvakumar, N ;
Iqbal, J ;
Trehan, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (02) :337-343
[10]   Small molecules with antimicrobial activity against E-coli and P-aeruginosa identified by high-throughput screening [J].
De La Fuente, R. ;
D Sonawane, N. ;
Arumainayagam, D. ;
Verkman, A. S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (05) :551-559